Sectors
INSP
Inspire Medical Systems, Inc.
54.99
600 x 54.60
200 x 54.54
bid
ask
+
1.35
2.52%
400 @ 04:00 PM
55.00 +0.01 (0.02%)
Ytd -40.38%
1y -65.54%
51.28
day range
55.02
50.13
52 week range
161.88
Open 52.62 Prev Close 53.64 Low 51.28 High 55.02 Mkt Cap 1.58B
Vol 851.82K Avg Vol 1.26M EPS 4.89 P/E 11.25 Forward P/E 20.45
Beta 0.78 Short Ratio 2.91 Inst. Own 119.87% Dividend N/A Div Yield N/A
Ex Div Date N/A Earning 05-04 50-d Avg 62.81 200-d Avg 90.78 1yr Est 79.42
Earning
Date For Estimate Reported Surprise surprise %
2026-05-04 2026-03 0 N/A N/A N/A
2026-02-11 2025-12 0.69 1.65 0.96 139.13%
2025-11-03 2025-09 0 0.38 0.53 353.33%
2025-08-04 2025-06 0.22 0.45 0.23 104.55%
2025-05-05 2025-03 0 0.1 0.33 143.48%
2025-02-10 2024-12 0.74 1.15 0.41 55.41%
Upgrade / Downgrade
Date Firm Action From To
2026-03-05 Stifel Upgrade Buy Buy
2026-02-13 Wolfe Research Downgrade Outperform Peer Perform
2026-02-12 Jefferies Upgrade Hold Hold
2026-02-12 RBC Capital Upgrade Sector Perform Sector Perform
2026-02-12 Piper Sandler Upgrade Overweight Overweight
2026-02-12 Truist Securities Upgrade Hold Hold
Profile
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Insider Holder
Date Name Relation Quantity Description
2025-08-28 BUCHHOLZ RICHARD Chief Financial Officer 50.77K Sale
2026-02-19 HERBERT TIMOTHY P Chief Executive Officer 163.49K Stock Award(Grant)
2026-02-19 MANN MELISSA Officer 23.61K Stock Award(Grant)
2025-12-01 MCCORMICK SHAWN T Director 27.85K Sale
2025-04-30 MEAD DANA G JR Director 22.65K Stock Award(Grant)
2024-04-28 NELSON MARILYN CARLSON Director 86.54K Conversion of Exercise of derivative security
Institution Ownership
Report Date Organization Position Value Percentage
2025-12-30 Blackrock Inc. 3.55M 195.26M 12.33%
2025-12-30 Vanguard Group Inc 2.95M 162.39M 10.26%
2025-12-30 Wellington Management Group, LLP 2.21M 121.59M 7.68%
2025-12-30 Deerfield Management Company, L.P 1.51M 82.81M 5.23%
2025-12-30 Morgan Stanley 1.26M 69.27M 4.38%
2025-12-30 Shaw D.E. & Co., Inc. 1.21M 66.66M 4.21%
Fund Ownership
Report Date Organization Position Value Percentage
2026-01-30 iShares Trust-iShares Core S&P Small-Cap ETF 1.59M 87.58M 5.53%
2026-01-30 VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund 1.09M 60.16M 3.80%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 899.59K 49.47M 3.12%
2026-01-30 Vanguard Explorer Fund 761.65K 41.88M 2.65%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund 658.80K 36.23M 2.29%
2025-11-29 VANGUARD WORLD FUND-Vanguard U.S. Growth Fund 577.84K 31.78M 2.01%
Dividend
Dividend Date
9 2008-01-09